We describe a mouse model of stroke induced by the occlusion of the middle cerebral artery using a silicone coated suture. The protocol can be applied to induce permanent occlusion or a temporary ischemia, followed by reperfusion.
Cerebrovascular disease is highly prevalent in the global population and encompasses several types of conditions, including stroke. To study the impact of stroke on tissue injury and to evaluate the effectiveness of therapeutic interventions, several experimental models in a variety of species were developed. They include complete global cerebral ischemia, incomplete global ischemia, focal cerebral ischemia, and multifocal cerebral ischemia. The model described in this protocol is based on the middle cerebral artery occlusion (MCAO) and is related to the focal ischemia category. This technique produces consistent focal ischemia in a strictly defined region of the hemisphere and is less invasive than other methods. The procedure described is performed on mice, given the availability of several genetic variants and the high number of tests standardized for mice to aid in the behavioral and neurodeficit evaluation.
The study of cardiovascular disease, such as stroke, relies on the use of in vivo models. To understand the possible implication of ischemia, drug toxicity, and/or treatment, there is a need to use a suitable, standardized, reliable, and reproducible model of the disease, which enables comparative studies between treatment groups. In this manuscript, we are using mice, given the availability of a large number of transgenic mice and standardized assessment models. Raking scores to assess motor and behavior deficits following experimental ischemic stroke and the following recovery have been developed1,2.
Several ischemic stroke models are available, such as complete global cerebral ischemia, incomplete global ischemia, multifocal cerebral ischemia and focal cerebral ischemia. The latter group is also the category of stroke most prevalent in patients. The majority of events are initiated by the formation of an embolic or thrombotic occlusion at or near the middle cerebral artery (MCA). Given these parameters, the model presented closely mimics disease etiology of human stroke and makes results obtained highly relevant3. Nevertheless, the translation of discoveries from animal models to disease treatment in humans has proven to be challenging. Up to now, only the use of thrombolytic tissue plasminogen activator has been approved for treatment of acute ischemic stroke4.
Among models of focal cerebral ischemia in mouse, posterior cerebral circulation stroke model and cerebral venous thrombosis model are highly invasive, diminishing their applicability and restricting the range of analyses that can be performed. However, other techniques, such as the embolic model, photothrombosis model, endothelin-1 induced stroke model, and intraluminal suture middle cerebral artery occlusion (MCAO) model, are available for use without such limitations. The MCAO model is a technique described in this protocol. It offers a reliable method of inducing focal cerebral ischemia that can be readily reperfused and performed in a high-throughput manner. There are two approaches to this model, namely, the Zea-Longa and Koizumi methods. They differ slightly in the way the occlusion suture is inserted in the vasculature. In the Zea-Longa technique, the suture is inserted via the external carotid artery5. The technique presented here is modified from the Koizumi method in which the occluding suture is inserted via the common carotid artery6.
The MCAO model has been successfully applied to evaluate different events occurring during ischemic stroke. Following reperfusion, brain edema can be observed along with the breakdown of the blood-brain barrier. Peak neuronal death is usually observed at 24 hr; however, it returns to baseline levels after 7 days7. In humans, sex and age are important variables when determining stroke outcome, this is also observed in mice and rats8,9,10. Several publications have used the MCAO model to demonstrate treatment efficiency11,12,13,14.
All procedures were approved by the University of Miami Institutional Animal Care and Use Committee (IACUC) in accordance with the National Institutes of Health (NIH) guidelines. The use to sterile equipment and aseptic techniques is required.
1. Preparing the Occlusion Suture
2. Preparation for Surgery
3. Dissection of the Common Carotid Artery and Internal/External Branching
4. Preparation of the CCA for the MCAO Suture Insertion
5. Middle Cerebral Artery Occlusion
6. Incision Closing and Post-operative Care
7. Reperfusion
8. Tissue Analysis
The insertion route for the occlusion suture is demonstrated in Figure 1. The MCAO suture is to be routed to the occlusion area, bifurcating in the ICA. Successful occlusion of the MCA will lead to tissue injury, visible by TTC staining. Figure 2 presents images of staining from sham treated animal (Figure 2A) and from a 60 min MCAO ischemia reperfusion animal (staining at 90 min or 24 hr post-occlusion, Figure 2B). To determine stroke volume, first calculate the stroke area for each section, using the ruler included in the imaging procedure, by subtracting the non-infarcted area of the ipsilateral side from the total area of the contralateral side. This calculation can be performed using commercial software or open source software. Afterward, calculate stroke volume for each slice taking into consideration that slides are 1 mm thick and sum the stroke volumes for all slices. This procedure will provide the total stroke volume for each animal, which can then be compared between different animal groups and treatments. On average, a 60 min occlusion followed by 23 hr of reperfusion results in a stroke volume of about 21 ± 3 mm3 in wild type non-treated C57BL/6J mice of 15 weeks old.
In addition to investigating stroke volume, immunofluorescence can be performed for a multitude of targets, such as microtubule-associated protein-2 (MAP2) for neuronal injury (Figure 3A) or glial fibrillary acidic protein (GFAP) for astrogliosis (Figure 3B). Such analyses further enable the analysis of stroke progression and recovery as well as other processes involved in stroke tissue damage and repair.
Figure 1: Schematic Representation of Brain Arterial Physiology. Route of the MCAO insertion proceeds from the common carotid artery (CCA) to the occlusion area indicated in blue. The surgery area is located at the bottom of the figure (Oval shape) and suture placement is indicated by black lines (TS: Top suture; MS: Middle suture; BS: Bottom suture). Please click here to view a larger version of this figure.
Figure 2: TTC Staining of Brain Sections. Top panel represent typical staining following sham insertion. Middle and bottom panels were obtained after a 60-minute MCAO, followed by 90 min or 24 hr of reperfusion. Scale bar is 1 mm.
Figure 3: Immunofluorescence Staining of Mouse Brain Following Stroke. Following a 60-minute occlusion, brains were reperfused for 23 hr, harvested, and processed for cryosectioning. Using antibodies to MAP2 (top) and GFAP (bottom), tissue was analyzed for neuronal injury and astroglyosis in either sham (left panels) or 90 min ischemia-reperfusion brains (right panels). Pictures presented are combined from multiple images taken by confocal microscopy using a 10X objective. Scale bar is 1 mm. Please click here to view a larger version of this figure.
Criteria of Evaluation | ||||
General Condition | Hair condition | Self-cleaning behavior (0: None; 2: normal) | ||
(0: Worst; 2: Normal) | Ears | Ears position (Droopy or raised) | ||
Hearing (Reactive or not) | ||||
Eye condition | Eyelid position | |||
Response | ||||
Posture | Crawling, leaning, normal | |||
Spontaneous activity | Unconscious/no movement, low activity, normal activity | |||
Neurodeficit | Body symmetry | When mouse is still (No movement, crawling, circling, partial leaning, normal) | ||
(0: Worst; 4: Normal) | Gait | No movement, rotating, circling, walking to one side, normal | ||
Climbing | Walking behavior on angled path (Same criteria as Gait) | |||
Circling behavior | Lifting animal by the tail (no movement, swirling, contracting to one side, both sides but with preference, normal) | |||
Front limb symmetry | Look at grabbing behavior of front paws (No grabbing at all, only one side grabs, both grab but one paw rigid, both grab but one continually loose first, normal) | |||
Compulsory circling | Put mouse on flat surface and push on shoulder from the side (No response/movement, rotating, falling to one side, leaning with resistance to push, normal) | |||
Whisker response | Touch whiskers one side at the time (No response, whiskers movement only, turn head, turn trunk, normal) | |||
Epileptic behavior | Behavior after sudden noise or light change (Unconscious, consistent general tonic spasm, transient general tonic spasm, transient focal tonic spasm, normal) |
Table 1. Scale for the Evaluation of Mouse Condition and Neurodeficit Following Ischemia Stroke. Adapted from1,2.
The successful utilization of the described MCAO method is highly dependent on an understanding of cerebral blood flow anatomy. Since the correct placement of the suture is hard to discern due to the lack of direct visual clues, repeated practice is important to master the procedure before using it for investigative studies. Stroke volume should be analyzed to ensure consistent results. The addition of a laser Doppler system can help to determine the successful occlusion of blood flow and should be used periodically to ensure that the procedure is done correctly. Routing the MCAO suture to the occlusion area can be facilitated by manipulating the artery. To help in guiding the suture to the MCA, once it has just passed the ECA/ICA branching, press against the ICA slightly above the branching (2-3 mm) with forceps to guide the suture to the left/down and prevent it from going into the pterygopalatine artery. In addition, moving the pillow placed in step 3.3 or pulling the bottom knot up and to the right can help in orienting the artery to ease the insertion. The remaining steps of the protocol involve microsurgery under stereomicroscope and are fairly straightforward. The success rate of the method described, as obtained by our group and reported by others, is of around 80 – 90%. Nevertheless, several factors can influence the survival, including body temperature control and suture selection 20,21,22. The maintenance of animal body temperature during surgery is important to improve animal survival.
Depending on the experience of the user, this method can be employed in a high throughput manner to study a large cohort of animals. The statistical significance of animal studies depends on the usage of sufficient number of subjects to discern between treatment groups despite intrinsic variation between animal subjects. The protocol presented enables such studies while recreating closely parts of the disease process.
The advantage of the MCAO technique is that, while it involves some surgical procedures, it does not require highly invasive procedures as in the craniotomy model. In addition, it is highly reproducible and the reperfusion is highly controllable, which is not possible using the endothelin-1 or the embolic stroke models. The technique closely mimics the process of a human ischemic stroke and produces characteristic tissue injury seen in humans, which is not the case for the photothrombosis model. As compared to other published techniques, the MCAO procedure does not require the cauterization of the ECA. This is an advantage since it can be combined with our ICA infusion model to deliver therapeutic agents to the affected hemisphere following stroke induction 23,24,25.
In addition to tissue analysis, animal behavior can be monitored to assess longitudinally the stroke severity and recovery. This can help compare recovery between different treatment groups. Several approaches have been developed in order to evaluate behavior. A simple 5 point scale can be used to evaluate neurological deficit post stroke (0: No behavior deficit; 1: No contralateral forepaw extension; 2: Circling on the contralateral side of infarct; 3: Falling on the contralateral side of infarct; 4: Low consciousness level and spontaneous movement) 5. In addition, in depth analysis of animal condition and behavior can be conducted to assess recovery as described in Table 11,2.
The surgical procedure presented uses a mechanical method for the induction of stroke, which limits utilization of this technique in studies on stroke susceptibility and/or causative agents. However, this protocol can be remarkably useful in analyzing stroke severity, preventive or mitigating strategies, aggravating factors and possible therapeutic approaches post-stroke. Comparison between treatment groups can help in identifying potential treatment that may minimize stroke damage or accelerate recovery. Indeed, enhancing recovery would be of great importance in helping stroke patients.
The authors have nothing to disclose.
We would like to thank Dr. Lei Chen (Icahn School of Medicine at Mount Sinai, NY) who first established this model in our laboratory. Supported in part by HL126559, DA039576, MH098891, MH63022, MH072567, DA027569, and NSC 2015/17/B/NZ7/02985. Dr. Luc Bertrand is supported in part by a postdoctoral fellowship from the American Heart Association (16POST31170002).
MCAO suture 0.23mm | Doccol | 702345PK5Re |
MCAO suture 0.21mm | Doccol | 702145PK5Re |
Silver pen | staples | 503205 |
Anesthesia machine | Vetequip | 901806 |
Surgical scissors | Fine science tool | 14558-09 |
Surgical forceps straight tip | Fine science tool | 00108-11 |
Surgical forceps angled tip | Fine science tool | 00109-11 |
Spring scissors | Fine science tool | 15000-08 |
Nylon suture | Braintree scintific | SUT-S 104 |
Closing suture | VWR | 95057-036 |
Isoflurane | Piramal | |
2,3,5-Triphenyltetrazolium chloride | FisherSci | 50-121-8005 |
Brain block | Braintree scintific | BS-A 5000C |
Cryostat blade | VWR | 89202-606 |
Optional: | ||
Periflux Laser doppler system | Perimed | Periflux 5000 |
Monitoring unit | Perimed | PF 5010 – LDPM |